Anne Goubier is Vice President Immunology at Tusk Therapeutics. She started her career at Merial (now Boehringer Animal Health), first as a veterinary scientist before rapidly progressing to head of the Immunology laboratory and of the adjuvant selection and validation platform. She has since dedicated her experience and expertise to human cancer immunotherapies research and development within small-sized companies such as Genticel and PX Biosolutions. Anne has a doctorate in Veterinary medicine and a Ph. D. in immunology from the University of Lyon.